Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01114841 · ClinicalTrials.gov registry record · Phase 1
A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers
A Phase 1 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 254
- Enrollment target
NCT01114841: Completed Phase 1 study, sponsored by Stiefel, a GSK Company.
NCT01114841 is a Phase 1 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 254 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (323% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01114841, a Phase 1 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 254 participants
- Enrollment target
Study Summary
This study will assess the potential of tazarotene foam to cause sensitization during a 48 hour challenge following 21 days of exposure on the skin of healthy volunteers.
Primary Outcome
Patch sites will be evaluated for signs of inflammatory skin responses (e.g. erythema, edema, papules) and superficial effects
Interventions
- DRUG Vehicle Foam
- DRUG Tazarotene Foam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2010-03-31 |
| Est. Completion | 2010-06-26 |
| Phase | Phase 1 |
What the finished NCT01114841 record still lists
NCT01114841 is an interventional study that assigns participants to a tested intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (323% higher).
The record links to 0 conditions, and to 2 interventions - of which Vehicle Foam is the first listed.
NCT01114841 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01114841 about?
NCT01114841 is a clinical study titled "A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers". This study will assess the potential of tazarotene foam to cause sensitization during a 48 hour challenge following 21 days of exposure on the skin of healthy volunteers.
What is the current status of trial NCT01114841?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 254 participants. The study started on 2010-03-31. Estimated completion is 2010-06-26.
What interventions are being tested in trial NCT01114841?
The interventions under investigation include: Vehicle Foam (DRUG), Tazarotene Foam (DRUG).
Who is sponsoring clinical trial NCT01114841?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01114841's enrollment target sits among peer trials
254 168th of 2000 higher than 1,832 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI